Spruce Biosciences Common Stock Market Value
| SPRB Stock | USD 76.60 4.20 5.80% |
| Symbol | Spruce |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spruce Biosciences. If investors know Spruce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Spruce Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (84.32) | Revenue Per Share | Quarterly Revenue Growth (0.76) | Return On Assets | Return On Equity |
Understanding Spruce Biosciences Common requires distinguishing between market price and book value, where the latter reflects Spruce's accounting equity. The concept of intrinsic value - what Spruce Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Spruce Biosciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between Spruce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spruce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Spruce Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Spruce Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Spruce Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Spruce Biosciences.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Spruce Biosciences on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Spruce Biosciences Common or generate 0.0% return on investment in Spruce Biosciences over 90 days. Spruce Biosciences is related to or competes with NRX Pharmaceuticals, Werewolf Therapeutics, OUTLOOK THERAPEUTICS, IO Biotech, Cue Biopharma, OS Therapies, and VTv Therapeutics. Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rar... More
Spruce Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Spruce Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Spruce Biosciences Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 31.24 | |||
| Value At Risk | (9.96) | |||
| Potential Upside | 10.15 |
Spruce Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spruce Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Spruce Biosciences' standard deviation. In reality, there are many statistical measures that can use Spruce Biosciences historical prices to predict the future Spruce Biosciences' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.99) | |||
| Treynor Ratio | (1.17) |
Spruce Biosciences February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (1.16) | |||
| Mean Deviation | 4.81 | |||
| Coefficient Of Variation | (1,682) | |||
| Standard Deviation | 6.2 | |||
| Variance | 38.39 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.99) | |||
| Treynor Ratio | (1.17) | |||
| Maximum Drawdown | 31.24 | |||
| Value At Risk | (9.96) | |||
| Potential Upside | 10.15 | |||
| Skewness | 0.1404 | |||
| Kurtosis | 0.5213 |
Spruce Biosciences Common Backtested Returns
Spruce Biosciences Common owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0909, which indicates the firm had a -0.0909 % return per unit of risk over the last 3 months. Spruce Biosciences Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Spruce Biosciences' Coefficient Of Variation of (1,682), risk adjusted performance of (0.04), and Variance of 38.39 to confirm the risk estimate we provide. The entity has a beta of 0.32, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Spruce Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Spruce Biosciences is expected to be smaller as well. At this point, Spruce Biosciences Common has a negative expected return of -0.54%. Please make sure to validate Spruce Biosciences' kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if Spruce Biosciences Common performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.38 |
Below average predictability
Spruce Biosciences Common has below average predictability. Overlapping area represents the amount of predictability between Spruce Biosciences time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Spruce Biosciences Common price movement. The serial correlation of 0.38 indicates that just about 38.0% of current Spruce Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.38 | |
| Spearman Rank Test | 0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 21.06 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Spruce Biosciences Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Spruce Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spruce Biosciences Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Spruce Biosciences Common Stock:Check out Spruce Biosciences Correlation, Spruce Biosciences Volatility and Spruce Biosciences Performance module to complement your research on Spruce Biosciences. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Spruce Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.